TY  - CHAP
M1  - Book, Section
TI  - Chapter 10. The FDA Perspective on Postmarket Drug Safety
A1  - Marchand, Heidi C.
A2  - Yang, Yi
A2  - West-Strum, Donna
Y1  - 2011
N1  - 
T2  - Understanding Pharmacoepidemiology
AB  - At  the  end  of  the  chapter,  the  reader  will  be  able  to:  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/25
UR  - accessbiomedicalscience.mhmedical.com/content.aspx?aid=57221965
ER  -